Genocea Biosciences Inc. (GNCA) Declined -6.48% or -0.04 To Price $0.5 On Friday

Genocea Biosciences Inc. (GNCA) declined -6.48% or -0.04 to $0.5. It is about 267935 shares traded, which is 92.47% compare to the average total volume 289768. The market cap of GNCA is $43.75 million. The year to date change is 13.76%. The 52 week price range is from $0.28 to $1.25. Price of GNCA have changed -5.28% during last week. It have changed 88.28% over last month, -16.83% over last 3 months, -14.08% over last 6 months and -41.41% over one year.

Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for GNCA is 0.53. It is 6.00% above current price. The 200-day Moving Averages for GNCA is 0.70. It is 40.00% above current price. The 52-week High is 1.25. It is 150.00% from the current price. The 52-week Low is 0.28. It is -44.00% from current price.

There are some statistics of GNCA. It is has market cap $43.75 million. The share outstanding is 86.63 million. The average volume is 289768. It has 12.27M cash and 14.31M in debt. The percent of top 15 Institution holding is 62.20%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of GNCA is -823.63%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of GNCA is -115.31%.


Share this post